Press Releases Related News

Annual Synthetic Biology Industry Investment Update Over $1 Billion USD Invested in Past 12 Months

London, UK – 13 March 2016 – SynBioBeta released today its annual Industry Investment Update, which you can download here: SynBioBeta 2017 Investment Update. Report highlights include: Over $1 billion USD invested in the last 12 months Over 410 companies in the industry [...]

By | March 13th, 2017|News, Press Releases|

Bolt Threads Brings a Glimpse of the Future of Advanced Materials to SXSW

Emeryville, Calif. – March 10, 2017 – Bolt Threads, a Bay Area-based biotechnology company creating the next generation of advanced materials, today unveiled the company’s first step towards commercial apparel production. At SXSW, the company will release a limited edition knit [...]

By | March 13th, 2017|Consumer Products & Manufacturing, News, Press Releases, Textiles|

Federal Regulatory Agencies Need to Prepare for Greater Quantity and Range of Biotechnology Products

WASHINGTON, March 9, 2017-- A profusion of biotechnology products is expected over the next five to 10 years, and the number and diversity of new products has the potential to overwhelm the U.S. regulatory system, says a new report from [...]

By | March 10th, 2017|News, Press Releases|

Researchers Assemble Five New Synthetic Yeast Chromosomes

MARCH 9, 2017 (2:00PM) - A global research team has built five new synthetic yeast chromosomes, meaning that 30 percent of a key organism’s genetic material has now been swapped out for engineered replacements. This is one of several findings of [...]

By | March 10th, 2017|News, Press Releases|

Molecular Assemblies Appoints Floyd E. Romesberg from The Scripps Research Institute to Scientific Advisory Board

SAN DIEGO, CA. — March 8, 2017— Molecular Assemblies Inc., a company developing a proprietary enzymatic DNA synthesis technology designed to power the next generation of DNA-based products, today announced that it has appointed Floyd E. Romesberg, PhD, a renowned [...]

By | March 10th, 2017|DNA Synthesis, Industry Providers, News, Press Releases|

Intellia Therapeutics Demonstrates Pioneering CRISPR/Cas9 Genome Editing Efficiency Data Using Lipid Nanoparticle Delivery Technology

CAMBRIDGE, Mass., March 08, 2017 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading genome editing company focused on the development of potentially curative therapies, today reported updated data showing increased levels of genome editing efficiency in vivo and durability [...]

By | March 9th, 2017|BioPharma & Healthcare, News, Press Releases, Therapeutics|